This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) in Focus: Stock Moves 9.2% Higher
by Zacks Equity Research
Centene (CNC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Humana's (HUM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Humana Inc.'s (HUM) Q3 earnings gain from Medicare Advantage enrollment, operational efficiency and lower impatient medical utilization
Tenet Healthcare's (THC) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings benefit on the back of USPI and Conifer Segments.
MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.
Ensign Group's (ENSG) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results gain from solid segmental performances.
Teladoc (TDOC) Q3 Loss Lower Than Estimates, Revenues Beat
by Zacks Equity Research
Teladoc's (TDOC) Q3 results show lower losses, revenues gain from increase in membership and patient visits.
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Cigna (CI) Q3 Earnings & Revenues Beat, Guidance Up
by Zacks Equity Research
Cigna (CI) Q3 earnings gain on revenue and membership growth.
WellCare Health (WCG) Q3 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
WellCare Health's (WCG) Q3 earnings beat estimates on the back of Meridian buyout, organic growth and higher membership.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings top on the back of a strong operating performance.
HCA Healthcare's (HCA) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings improve on the back of rising admissions.
Universal Health (UHS) Q3 Earnings Beat, 2018 View Narrows
by Zacks Equity Research
Universal Health's (UHS) Q3 benefits from an improved performance at both its segments.
Centene's (CNC) Earnings and Revenues Top Estimates in Q3
by Zacks Equity Research
Execution of growth strategy as well as the company's solid operating metrics leads Centene (CNC) to an earnings beat in Q3.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JHMM
Centene (CNC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 1.13% and 0.56%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) third quarter should exhibit strong performances by its Government-backed and Medicaid businesses.
Centene (CNC) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene (CNC) Reaches 52-Week High on Solid 2Q18 Performance
by Zacks Equity Research
Riding high on five main factors, Centene's (CNC) shares scale a 52-week high on Aug 10, 2018.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Tenet Healthcare (THC) Q2 Earnings Top & Up Y/Y, Revenues Lag
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings impress with solid performances at the Ambulatory Segment.
Envision Healthcare (EVHC) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Envision Healthcare (EVHC) Q2 earnings were backed by higher contribution from its segments.
Aetna (AET) Q2 Earnings Beat Estimates, Membership Declines
by Zacks Equity Research
Aetna's (AET) Q2 earnings gained from a lower tax rate partly offset by increase in expenses.
Cigna (CI) Q2 Earnings & Revenues Beat, 2018 View Raised
by Zacks Equity Research
Cigna's (CI) Q2 earnings gain on premium and customer growth.
Teladoc (TDOC) Incurs Narrower-Than-Expected Loss in Q2
by Zacks Equity Research
Teladoc (TDOC) incurs loss owing to high expenses, partly offset by revenue growth.
Humana (HUM) Surpasses on Q2 Earnings, Raises EPS Guidance
by Zacks Equity Research
Humana's (HUM) Q2 earnings register growth on the back of Medicare Advantage enrollment and solid strategies. The company also lifts its EPS outlook.